MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Technology Scientific & Technical Instruments

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Post by Parrotheadon Sep 04, 2020 9:35am

142 Views

Post# 31509600

Show Time!

Fasten your seat belts and pour yourself a stiff one. Going to be a fun day.

Wish we had more sales data and could derive some fair evaluation for the company.

$1 share = 600 million cap.
$2 share = $1.2 million cap.

Personally, think their value is somewhere in between. Then of course there is the premium for the category, shareholder excitement, etc. Just like many of the cannabis companies in the beginning.

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal